Evidence map›Paper›PMID 29354725›Full record

ArticleBMJ open ophthalmology2017

Neither non-toxigenic

Dayu Li, Robin R Hodges, Paulo Bispo, Michael S Gilmore, Meredith Gregory-Ksander, Darlene A Dartt

Open access · goldAbstract read
In one paragraph

Article in BMJ open ophthalmology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Frontiers in cellular and infection microbiology · 2023
    Article
  2. Article
  3. NOD-like Receptors in the Eye: Uncovering Its Role in Diabetic Retinopathy.International journal of molecular sciences · 2020
    Review
  4. Article
  5. Review
  6. Immunoresolvent Resolvin D1 Maintains the Health of the Ocular Surface.Advances in experimental medicine and biology · 2019
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Dayu LiSchepens Eye Research Institute/Massachusetts Eye and Ear, Boston, Massachusetts, USA.
Robin R HodgesSchepens Eye Research Institute/Massachusetts Eye and Ear, Boston, Massachusetts, USA.
Paulo BispoDepartment of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA.
Michael S GilmoreDepartment of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA.
Meredith Gregory-KsanderSchepens Eye Research Institute/Massachusetts Eye and Ear, Boston, Massachusetts, USA.
Darlene A DarttSchepens Eye Research Institute/Massachusetts Eye and Ear, Boston, Massachusetts, USA.
Massachusetts Eye and Ear Infirmary · USHarvard University · USSmith-Kettlewell Eye Research Institute · US

Funding

Conjunctival Goblet Cell NLRP3 Inflammasome in Ocular Surface Bacterial InfectionR01EY022415 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI DARTT, DARLENE A · 2012 to 2015
$1.7M
NEI NIH HHS R01 EY022415
6 · The paper itself

Abstract

purposeThe conjunctiva is a wet mucosal surface surrounding the cornea that is continuously exposed to pathogens. Nevertheless, persistent inflammation is not observed. We examined if the NOD-like receptor pyrin domain 3 (NLRP3) inflammasome functions as a sensor that distinguishes commensal and non-pathogenic bacteria from pathogenic bacteria in human conjunctival goblet cells.

methodsGoblet cells were grown from human conjunctiva and co-cultured with commensal

resultsWhile all three strains of bacteria were able to bind to goblet cells, neither commensal

conclusionsWe conclude that NLRP3 serves as a sensor capable of discriminating commensal and non-pathogenic bacteria from pathogenic bacteria in conjunctival goblet cells, and that activation of the NLRP3 inflammasome induced by pathogenic bacteria mediates secretion of both mature IL-1β and large secretory mucins from these cells.

Indexed as

infectioninflammation

Identifiers

PMID29354725
PMCPMC5751869
OpenAlexW2770292471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.